GREGORY QUINLAN: Open Payments
NPI 1588628333 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,935 in 89 payments from 18 companies in 2025. Trend: 2023 $1,698 · 2024 $2,072 · 2025 $1,935
Food & beverage: $1,935
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $401 |
| E.R. Squibb & Sons, L.L.C. | 11 | $328 |
| Alnylam Pharmaceuticals Inc. | 6 | $173 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $158 |
| SCPHARMACEUTICALS INC. | 7 | $137 |
| Novo Nordisk Inc | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| PFIZER INC. | 3 | $74 |
| Esperion Therapeutics, Inc. | 4 | $72 |
Products named: LEQVIO, ELIQUIS, CAMZYOS, LifeVest, JARDIANCE, FUROSCIX, Wegovy, ONPATTRO.
Industry payments across MA — which companies pay providers there.
